cysteamine 4.4 MG/ML Ophthalmic Solution

RxCUI: 1313780
RxNorm name: cysteamine 4.4 MG/ML Ophthalmic Solution
Display name: cysteamine 4.4 MG/ML Ophthalmic Solution
Full name: cysteamine 4.4 MG/ML Ophthalmic Solution
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CYSTARAN	CYSTEAMINE HYDROCHLORIDE	Leadiant Biosciences, Inc.	b98ee838-ed23-42a9-93b5-72579e490fba	2025-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 1313780

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b98ee838-ed23-42a9-93b5-72579e490fba	cysteamine 4.4 MG/ML Ophthalmic Solution	SCD	23	These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994	20250430
b98ee838-ed23-42a9-93b5-72579e490fba	cysteamine 4.4 MG/ML (as cysteamine hydrochloride 6.5 MG/ML) Ophthalmic Solution	SY	23	These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994	20250430
b98ee838-ed23-42a9-93b5-72579e490fba	cysteamine 0.44 % Ophthalmic Solution	SY	23	These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994	20250430
b98ee838-ed23-42a9-93b5-72579e490fba	cysteamine HCl 0.44 % Ophthalmic Solution	PSN	23	These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994	20250430